Sponsored Links
| FDA Accepts Filing Of New Drug Application For Nycomed's Ciclesonide HFA Nasal Aerosol |
 |
 |
 |
| Medical News - Allergy | |||
|
Nycomed's licensing partner Sunovion Pharmaceuticals Inc. (Sunovion) announced today that the U.S. Food and Drug Administration (FDA) has accepted the filing of the New Drug Application (NDA) submitted for ciclesonide nasal aerosol in a hydrofluoroalkane (HFA) formulation... Read more: Allergy News From Medical News Today
|